BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33622891)

  • 1. Cytotoxic T-lymphocyte Antigen-4 (
    VAN Nguyen S; Shamoun L; Landerholm K; Andersson RE; Wagsater D; Dimberg J
    In Vivo; 2021; 35(2):969-975. PubMed ID: 33622891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of Association between CTLA-4 Gene Polymorphisms and Colorectal Cancers in Saudi Patients.
    Al-Harbi N; Abdulla MH; Vaali-Mohammed MA; Bin Traiki T; Alswayyed M; Al-Obeed O; Abid I; Al-Omar S; Mansour L
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological and prognostic value of CD44 gene polymorphism (rs187115) in Swedish patients with colorectal cancer.
    Nguyen SV; Shamoun L; Landerholm K; Wågsäter D; Dimberg J
    Nucleosides Nucleotides Nucleic Acids; 2023; 42(10):807-817. PubMed ID: 37074032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTLA-4 +49A>G polymorphism is associated with the risk but not with the progression of colorectal cancer in Chinese.
    Qi P; Ruan CP; Wang H; Zhou FG; Xu XY; Gu X; Zhao YP; Dou TH; Gao CF
    Int J Colorectal Dis; 2010 Jan; 25(1):39-45. PubMed ID: 19787358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Thyroid Cancer and CTLA-4 Gene Polymorphisms.
    Sun L; Niu T; Zhang Y
    Cell Mol Biol (Noisy-le-grand); 2023 Apr; 69(4):31-36. PubMed ID: 37329551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between co-inhibitory molecule gene tagging single nucleotide polymorphisms and the risk of colorectal cancer in Chinese.
    Ge J; Zhu L; Zhou J; Li G; Li Y; Li S; Wu Z; Rong J; Yuan H; Liu Y; Chi Q; Piao D; Zhao Y; Cui B
    J Cancer Res Clin Oncol; 2015 Sep; 141(9):1533-44. PubMed ID: 25604582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTLA-4 polymorphism contributes to the genetic susceptibility of epithelial ovarian cancer.
    Chen J; Kang S; Wu J; Zhao J; Si W; Sun H; Li Y
    J Obstet Gynaecol Res; 2022 May; 48(5):1240-1247. PubMed ID: 35150042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variations in cytotoxic T-lymphocyte antigen-4 and susceptibility to cervical cancer.
    Xiong YH; He L; Fei J
    Int Immunopharmacol; 2014 Jan; 18(1):71-6. PubMed ID: 24201079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The -319C/+49G/CT60G haplotype of CTLA-4 gene confers susceptibility to rheumatoid arthritis in Mexican population.
    Torres-Carrillo N; Ontiveros-Mercado H; Torres-Carrillo NM; Parra-Rojas I; Rangel-Villalobos H; Ramírez-Dueñas MG; Gutiérrez-Ureña SR; Valle Y; Muñoz-Valle JF
    Cell Biochem Biophys; 2013; 67(3):1217-28. PubMed ID: 23703660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of CTLA-4 A49G polymorphism with colorectal cancer risk in a Chinese Han population.
    Wang Y; Wang X; Zhao R
    Int J Immunogenet; 2015 Apr; 42(2):93-9. PubMed ID: 25689638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cytotoxic T-Lymphocyte antigen-4+49A/G gene polymorphism in cutaneous leishmaniasis.
    Al-Ghabban MJS; Al-Bayati NY; Al-Mayah QS; Al-Matubsi HY
    Microb Pathog; 2021 Sep; 158():105073. PubMed ID: 34182077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma.
    Liu Y; He Z; Feng D; Shi G; Gao R; Wu X; Song W; Yuan W
    DNA Cell Biol; 2011 Dec; 30(12):1051-5. PubMed ID: 21612409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTLA-4 and MDR1 polymorphisms increase the risk for ulcerative colitis: A meta-analysis.
    Zhao JJ; Wang D; Yao H; Sun DW; Li HY
    World J Gastroenterol; 2015 Sep; 21(34):10025-40. PubMed ID: 26379408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCV F protein amplifies the predictions of IL-28B and CTLA-4 polymorphisms about the susceptibility and outcomes of HCV infection in Southeast China.
    Xiao W; Zhang Q; Deng XZ; Jiang LF; Zhu DY; Pei JP; Ge CY; Li BJ; Wang CJ; Zhang JH; Zhou ZX; Ding WL; Xu XD; Yue M
    Infect Genet Evol; 2015 Aug; 34():52-60. PubMed ID: 26079279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of cytotoxic T-lymphocyte antigen 4 rs231775 gene polymorphism with colorectal cancer risk.
    Zhang Y; Zhang S; Xia W; Dong Z
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S526-S532. PubMed ID: 29970719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between CTLA-4 gene polymorphism and myasthenia gravis in a Chinese cohort.
    Cai GM; Gao Z; Yue YX; Xie YC; Gao X; Hao HJ; Zhang XJ; Wang Q; Liang B; Li HF
    J Clin Neurosci; 2019 Nov; 69():31-37. PubMed ID: 31473094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of CTLA-4 gene polymorphism with end-stage renal disease and renal allograft outcome.
    Misra MK; Kapoor R; Pandey SK; Sharma RK; Agrawal S
    J Interferon Cytokine Res; 2014 Mar; 34(3):148-61. PubMed ID: 24313821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic T lymphocyte antigen-4 +49A/G polymorphism does not affect susceptibility to autoimmune hepatitis.
    van Gerven NM; de Boer YS; Zwiers A; van Hoek B; van Erpecum KJ; Beuers U; van Buuren HR; Drenth JP; den Ouden JW; Verdonk RC; Koek GH; Brouwer JT; Guichelaar MM; Vrolijk JM; Kraal G; Mulder CJ; van Nieuwkerk CM; Bouma G;
    Liver Int; 2013 Aug; 33(7):1039-43. PubMed ID: 23551963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTLA-4 CT60 (rs3087243) polymorphism and autoimmune thyroid diseases susceptibility: a comprehensive meta-analysis.
    Ni J; Qiu LJ; Zhang M; Wen PF; Ye XR; Liang Y; Pan HF; Ye DQ
    Endocr Res; 2014; 39(4):180-8. PubMed ID: 24697361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study on cytotoxic T lymphocyte-4 gene polymorphisms in urinary schistosomiasis.
    Idris ZM; Yazdanbakhsh M; Adegnika AA; Lell B; Issifou S; Noordin R
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):488-92. PubMed ID: 22288822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.